Precigen appoints Harry Thomasian Jr. as CFO effective Oct 18, 2021

PRECIGEN, INC.

Harry Thomasian Jr., 59, appointed CFO, effective October 18, 2021; succeeds interim CFO James V. Lambert.
Thomasian previously a partner at EY for 19 years, life sciences and capital markets experience.
Compensation: base salary $440,000.16, target annual bonus 40% of base, stock options for 180,000 shares vesting over 4 years.
Appointment fills CFO role vacant since Rick Sterling resigned April 2021; search completed.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change (interim)

James V. Lambert

Interim Principal Accounting Officer

PGEN · PRECIGEN, INC.

Effective: 2021-10-18
Filed: October 12, 2021, 7:59 PM ET

James V. Lambert, who has served as interim principal accounting officer of the Company since Mr. Osborne's resignation, will step down from that position effective upon Mr. Thomasian's start date, and will continue to serve as Executive Director, Finance for PGEN Therapeutics, Inc., a wholly owned subsidiary of the Company.

Appointed

Harry Thomasian Jr.

Chief Financial Officer

PGEN · PRECIGEN, INC.

Effective: 2021-10-18
Filed: October 12, 2021, 7:59 PM ET

On October 12, 2021, Precigen, Inc. (the “Company”), announced that Harry Thomasian Jr., age 59, was appointed Chief Financial Officer of the Company, effective October 18, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.9

James V. Lambert changed role as Interim Principal Accounting Officer at PRECIGEN, INC..

Action: stepped down
Role: Interim Principal Accounting Officer

Exact text from the filing

James V. Lambert, who has served as interim principal accounting officer of the Company since Mr. Osborne's resignation, will step down from that position effective upon Mr. Thomasian's start date, and will continue to serve as Executive Director, Finance for PGEN Therapeutics, Inc., a wholly owned subsidiary of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Harry Thomasian Jr. was appointed as Chief Financial Officer at PRECIGEN, INC..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On October 12, 2021, Precigen, Inc. (the “Company”), announced that Harry Thomasian Jr., age 59, was appointed Chief Financial Officer of the Company, effective October 18, 2021.

View on SEC.gov

PRECIGEN, INC. filing history →

Source: SEC EDGAR

accession 0000950103-21-015724

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.